López-Pedret J - Search Results

1

Reticulated platelets in uremic patients: effect of hemodialysis and continuous ambulatory peritoneal dialysis.

Tàssies D, Reverter JC, Cases A, Escolar G, Villamor N, López-Pedret J, Castillo R, Ordinas A. Tàssies D, et al. Am J Hematol. 1995 Nov;50(3):161-6. doi: 10.1002/ajh.2830500303. Am J Hematol. 1995. PMID: 7485076

2

[Effects of the treatment with human recombinant erythropoietin on primary hemostasis in uremic patients].

Cases A, Escolar G, Reverter JC, Garrido M, Ordinas A, López-Pedret J, Castillo R, Revert L. Cases A, et al. Med Clin (Barc). 1990 Nov 17;95(17):644-7. Med Clin (Barc). 1990. PMID: 2089202 Spanish.

3

Platelet activation on hemodialysis: influence of dialysis membranes.

Cases A, Reverter JC, Escolar G, Sanz C, Lopez-Pedret J, Revert L, Ordinas A. Cases A, et al. Kidney Int Suppl. 1993 Jun;41:S217-20. Kidney Int Suppl. 1993. PMID: 8320925 Clinical Trial.

4

Erythropoietin improves signaling through tyrosine phosphorylation in platelets from uremic patients.

Diaz-Ricart M, Etebanell E, Cases A, López-Pedret J, Castillo R, Ordinas A, Escolar G. Diaz-Ricart M, et al. Thromb Haemost. 1999 Oct;82(4):1312-7. Thromb Haemost. 1999. PMID: 10544920

5

Abnormal platelet cytoskeletal assembly in hemodialyzed patients results in deficient tyrosine phosphorylation signaling.

Díaz-Ricart M, Estebanell E, Cases A, Calls J, López-Pedret J, Carretero M, Castillo R, Ordinas A, Escolar G. Díaz-Ricart M, et al. Kidney Int. 2000 May;57(5):1905-14. doi: 10.1046/j.1523-1755.2000.00040.x. Kidney Int. 2000. PMID: 10792609 Free article.

6

Recombinant human erythropoietin treatment improves platelet function in uremic patients.

Cases A, Escolar G, Reverter JC, Ordinas A, Lopez-Pedret J, Revert L, Castillo R. Cases A, et al. Kidney Int. 1992 Sep;42(3):668-72. doi: 10.1038/ki.1992.333. Kidney Int. 1992. PMID: 1405344 Free article.

7

Tumor markers in chronic renal failure and hemodialysis patients.

Cases A, Filella X, Molina R, Ballesta AM, Lopez-Pedret J, Revert L. Cases A, et al. Nephron. 1991;57(2):183-6. doi: 10.1159/000186247. Nephron. 1991. PMID: 2020345

8

Visceral involvement of dialysis amyloidosis.

Campistol JM, Cases A, Torras A, Soler M, Muñoz-Gómez J, Montoliu J, López-Pedret J, Revert L. Campistol JM, et al. Am J Nephrol. 1987;7(5):390-3. doi: 10.1159/000167505. Am J Nephrol. 1987. PMID: 3434597

9

Patients with multiple myeloma requiring long-term dialysis: presenting features, response to therapy, and outcome in a series of 20 cases.

Torra R, Bladé J, Cases A, López-Pedret J, Montserrat E, Rozman C, Revert L. Torra R, et al. Br J Haematol. 1995 Dec;91(4):854-9. doi: 10.1111/j.1365-2141.1995.tb05400.x. Br J Haematol. 1995. PMID: 8547129

10

Uremic medium disturbs the hemostatic balance of cultured human endothelial cells.

Serradell M, Díaz-Ricart M, Cases A, Zurbano MJ, Aznar-Salatti J, López-Pedret J, Ordinas A, Escolar G. Serradell M, et al. Among authors: lopez pedret j. Thromb Haemost. 2001 Oct;86(4):1099-105. Thromb Haemost. 2001. PMID: 11686330

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters